Endocrine Effects of the Tyrosine Kinase Inhibitor Vandetanib in Patients Treated for Thyroid Cancer

Purpose: The purpose of the study was to assess the endocrine effects of vandetanib, a multikinase inhibitor targeting RET, vascular endothelial growth factor receptor, and epidermal growth factor receptor, in 39 patients with progressive thyroid cancer included in two randomized placebo-controlled...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The journal of clinical endocrinology and metabolism 2011-09, Vol.96 (9), p.2741-2749
Hauptverfasser: Brassard, Maryse, Neraud, Barbara, Trabado, Séverine, Salenave, Sylvie, Brailly-Tabard, Sylvie, Borget, Isabelle, Baudin, Eric, Leboulleux, Sophie, Chanson, Philippe, Schlumberger, Martin, Young, Jacques
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!